News
Latest News
Stay informed on news about bladder cancer, UROBEST development, company news… Follow us
Fina Biotech reinforces its IP portfolio with a new patent in Europe
Fina Biotech announces that the European Patent Office (EPO) has granted patent number EP2951315 to protect a ´NON-INVASIVE DIAGNOSTIC METHOD [...]
Read More >
FINA BIOTECH has recently obtained a grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models
Fina Biotech has obtained for the 12th consecutive year the grant from the OEPM (Spanish Patent and Trademark Office) for [...]
Read More >
FINA BIOTECH announces its merger by absorption with BIOFINA DIAGNOSTICS
FINA BIOTECH (acquiring company) has recently completed its merger by absorption with BIOFINA DIAGNOSTICS (acquired company). Both companies took the [...]
Read More >
“Signatures of 2, 5, 10 and 12 genes have been identified. They all display strong diagnostic performance”
“There is a real and proven demand among urologists to develop a non-invasive method for monitoring bladder cancer patients”
“Only a urine sample from the patient is enough to diagnose bladder cancer. RT-PCR technology allows us to measure the genetic expression and give us quantitative results”